Characterization of EpCAM in thyroid cancer biology by three-dimensional spheroids in vitro model

[1]  Yurong Lu,et al.  Vemurafenib activates the sonic hedgehog pathway and promotes thyroid cancer stem cell self-renewal. , 2023, Endocrine-related cancer.

[2]  O. Merkel,et al.  An In Vitro Approach to Model EMT in Breast Cancer , 2023, International journal of molecular sciences.

[3]  L. Persani,et al.  FAM83B is involved in thyroid cancer cell differentiation and migration , 2022, Scientific Reports.

[4]  M. Ringel,et al.  Thyroid cancer, recent advances in diagnosis and therapy , 2021, International journal of cancer.

[5]  M. Tomlinson,et al.  The metalloproteinase ADAM10 requires its activity to sustain surface expression , 2020, Cellular and Molecular Life Sciences.

[6]  Raymond B. Runyan,et al.  Guidelines and definitions for research on epithelial–mesenchymal transition , 2020, Nature Reviews Molecular Cell Biology.

[7]  E. Grassi,et al.  Hypoxia-induced release, nuclear translocation, and signaling activity of a DLK1 intracellular fragment in glioma , 2020, Oncogene.

[8]  M. Hedayati,et al.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review , 2019, Endocrine.

[9]  F. Azuaje,et al.  Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment , 2019, Nature Communications.

[10]  O. Gires,et al.  Membrane-associated epithelial cell adhesion molecule is slowly cleaved by γ-secretase prior to efficient proteasomal degradation of its intracellular domain , 2018, The Journal of Biological Chemistry.

[11]  A. Pietras,et al.  The p75 neurotrophin receptor enhances HIF‐dependent signaling in glioma , 2018, Experimental cell research.

[12]  B. Lenarčič,et al.  EpCAM ectodomain EpEX is a ligand of EGFR that counteracts EGF-mediated epithelial-mesenchymal transition through modulation of phospho-ERK1/2 in head and neck cancers , 2018, PLoS biology.

[13]  Joseph Szymborski,et al.  Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer , 2018, Oncogene.

[14]  D. Lindgren,et al.  CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. , 2017, Cell reports.

[15]  H. Saya,et al.  The impact of EpCAM expression on response to chemotherapy and clinical outcomes in patients with epithelial ovarian cancer , 2017, Oncotarget.

[16]  C. Compton,et al.  The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging , 2017, CA: a cancer journal for clinicians.

[17]  N. McGranahan,et al.  Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.

[18]  V. Vaira,et al.  Multicellular spheroids from normal and neoplastic thyroid tissues as a suitable model to test the effects of multikinase inhibitors , 2016, Oncotarget.

[19]  G. Semenza,et al.  Hypoxia-Inducible Factors: Master Regulators of Cancer Progression. , 2016, Trends in cancer.

[20]  Jianhua Ruan,et al.  EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition. , 2016, Cancer research.

[21]  C. Barrias,et al.  A 3D in vitro model to explore the inter-conversion between epithelial and mesenchymal states during EMT and its reversion , 2016, Scientific Reports.

[22]  G. Semenza.  Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors. , 2015, Clinical science.

[23]  G. Vitale,et al.  SP600125 has a remarkable anticancer potential against undifferentiated thyroid cancer through selective action on ROCK and p53 pathways , 2015, Oncotarget.

[24]  M. Charbonneau,et al.  High Glucose Up-regulates ADAM17 through HIF-1α in Mesangial Cells* , 2015, The Journal of Biological Chemistry.

[25]  L. weiswald,et al.  Spherical Cancer Models in Tumor Biology1 , 2015, Neoplasia.

[26]  T. Kirkegaard,et al.  The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines. , 2014, International journal of oncology.

[27]  T. Okada,et al.  Coexpression of EpCAM, CD44 Variant Isoforms and Claudin-7 in Anaplastic Thyroid Carcinoma , 2014, PloS one.

[28]  G. Mazzoleni,et al.  Loss of membranous expression of the intracellular domain of EpCAM is a frequent event and predicts poor survival in patients with pancreatic cancer , 2014, Histopathology.

[29]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[30]  S. Yamashita,et al.  Analysis of multiple markers for cancer stem-like cells in human thyroid carcinoma cell lines. , 2014, Endocrine journal.

[31]  G. Clayman,et al.  Detection of thyroid cancer stem cells in papillary thyroid carcinoma. , 2014, The Journal of clinical endocrinology and metabolism.

[32]  Jian-kui Han,et al.  Thyroid tumor-initiating cells: Increasing evidence and opportunities for anticancer therapy (Review) , 2014, Oncology reports.

[33]  B. Giepmans,et al.  EpCAM: structure and function in health and disease. , 2013, Biochimica et biophysica acta.

[34]  D. Cui,et al.  Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. , 2013, International journal of oncology.

[35]  R. Oehler,et al.  Vimentin cleavage in end-stage renal disease is not related to apoptosis , 2013 .

[36]  Min Li,et al.  ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway , 2013, Molecular and Cellular Biochemistry.

[37]  B. Giepmans,et al.  EpCAM proteolysis: new fragments with distinct functions? , 2013, Bioscience reports.

[38]  B. Mack,et al.  EpCAM regulates cell cycle progression via control of cyclin D1 expression , 2013, Oncogene.

[39]  F. Papaccio,et al.  Cancer stem cells in solid tumors: an overview and new approaches for their isolation and characterization , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  H. Hamada,et al.  EpCAM contributes to formation of functional tight junction in the intestinal epithelium by recruiting claudin proteins. , 2012, Developmental biology.

[41]  Wenxiu Zhao,et al.  Embryonic Stem Cell Markers , 2012, Molecules.

[42]  S. Chiou,et al.  Targeting Signal Transducer and Activator of Transcription 3 Pathway by Cucurbitacin I Diminishes Self-Renewing and Radiochemoresistant Abilities in Thyroid Cancer-Derived CD133+ Cells , 2012, Journal of Pharmacology and Experimental Therapeutics.

[43]  Arun K. Ghosh,et al.  Developing β‐secretase inhibitors for treatment of Alzheimer’s disease , 2012, Journal of neurochemistry.

[44]  K. Akassoglou,et al.  Oxygen-dependent cleavage of the p75 neurotrophin receptor triggers stabilization of HIF-1α. , 2011, Molecular cell.

[45]  Hsiang-Po Huang,et al.  Epithelial Cell Adhesion Molecule (EpCAM) Complex Proteins Promote Transcription Factor-mediated Pluripotency Reprogramming* , 2011, The Journal of Biological Chemistry.

[46]  Reigh-Yi Lin.  Thyroid cancer stem cells , 2011, Nature Reviews Endocrinology.

[47]  L. Vermeulen,et al.  Cancer stem cell niche: the place to be. , 2011, Cancer research.

[48]  S. S. Chauhan,et al.  Nuclear and Cytoplasmic Accumulation of Ep-ICD Is Frequently Detected in Human Epithelial Cancers , 2010, PloS one.

[49]  R. Ralhan,et al.  EpCAM nuclear localization identifies aggressive Thyroid Cancer and is a marker for poor prognosis , 2010, BMC Cancer.

[50]  G. Smyth,et al.  ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. , 2009, Journal of immunological methods.

[51]  E. Neilson,et al.  Biomarkers for epithelial-mesenchymal transitions. , 2009, The Journal of clinical investigation.

[52]  T. Wang,et al.  Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.

[53]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[54]  Takashi Sakurai,et al.  Crystal Structure of an Active Form of BACE1, an Enzyme Responsible for Amyloid β Protein Production , 2008, Molecular and Cellular Biology.

[55]  D. Deforce,et al.  Differential proteome analysis of normal and osteoarthritic chondrocytes reveals distortion of vimentin network in osteoarthritis. , 2008, Osteoarthritis and cartilage.

[56]  H. Scholz,et al.  Hypoxia-inducible Factor-1 (HIF-1) Is a Transcriptional Activator of the TrkB Neurotrophin Receptor Gene* , 2007, Journal of Biological Chemistry.

[57]  J. Dick,et al.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.

[58]  G. Sauter,et al.  High Ep-CAM Expression is Associated with Poor Prognosis in Node-positive Breast Cancer , 2004, Breast Cancer Research and Treatment.

[59]  G. Schäfer,et al.  Overexpression of Epithelial Cell Adhesion Molecule Antigen in Gallbladder Carcinoma Is an Independent Marker for Poor Survival , 2004, Clinical Cancer Research.

[60]  C. Holding,et al.  Human embryonic genes re-expressed in cancer cells , 2001, Oncogene.

[61]  H. A. Bakker,et al.  The structural analysis of adhesions mediated by Ep-CAM. , 1999, Experimental cell research.

[62]  H. A. Bakker,et al.  Cytoplasmic Tail Regulates the Intercellular Adhesion Function of the Epithelial Cell Adhesion Molecule , 1998, Molecular and Cellular Biology.

[63]  H. A. Bakker,et al.  Epithelial Cell Adhesion Molecule (Ep-CAM) Modulates Cell–Cell Interactions Mediated by Classic Cadherins , 1997, The Journal of cell biology.

[64]  H. A. Bakker,et al.  Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule , 1994, The Journal of cell biology.

[65]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[66]  M. Herlyn,et al.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[67]  I. Căruntu,et al.  EpCAM (MOC-31) - immunohistochemical profile and clinico-pathological correlations in different histological variants of papillary thyroid carcinoma. , 2019, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[68]  M. Charbonneau,et al.  Hypoxia-inducible factor mediates hypoxic and tumor necrosis factor alpha-induced increases in tumor necrosis factor-alpha converting enzyme/ADAM17 expression by synovial cells. , 2007, The Journal of biological chemistry.